BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 32041611)

  • 1. Six years' experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias.
    Dron JS; Wang J; McIntyre AD; Iacocca MA; Robinson JF; Ban MR; Cao H; Hegele RA
    BMC Med Genomics; 2020 Feb; 13(1):23. PubMed ID: 32041611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias.
    Johansen CT; Dubé JB; Loyzer MN; MacDonald A; Carter DE; McIntyre AD; Cao H; Wang J; Robinson JF; Hegele RA
    J Lipid Res; 2014 Apr; 55(4):765-72. PubMed ID: 24503134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2019 George Lyman Duff Memorial Lecture: Three Decades of Examining DNA in Patients With Dyslipidemia.
    Hegele RA; Dron JS
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):1970-1981. PubMed ID: 32762461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The polygenic nature of mild-to-moderate hypertriglyceridemia.
    Dron JS; Wang J; McIntyre AD; Cao H; Hegele RA
    J Clin Lipidol; 2020; 14(1):28-34.e2. PubMed ID: 32033914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polygenic scores for dyslipidemia: the emerging genomic model of plasma lipoprotein trait inheritance.
    Trinder M; Brunham LR
    Curr Opin Lipidol; 2021 Apr; 32(2):103-111. PubMed ID: 33395106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe hypertriglyceridemia is primarily polygenic.
    Dron JS; Wang J; Cao H; McIntyre AD; Iacocca MA; Menard JR; Movsesyan I; Malloy MJ; Pullinger CR; Kane JP; Hegele RA
    J Clin Lipidol; 2019; 13(1):80-88. PubMed ID: 30466821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants influencing lipid levels and risk of dyslipidemia in Chinese population.
    Luo H; Zhang X; Shuai P; Miao Y; Ye Z; Lin Y
    J Genet; 2017 Dec; 96(6):985-992. PubMed ID: 29321358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Contribution of GWAS Loci in Familial Dyslipidemias.
    Ripatti P; Rämö JT; Söderlund S; Surakka I; Matikainen N; Pirinen M; Pajukanta P; Sarin AP; Service SK; Laurila PP; Ehnholm C; Salomaa V; Wilson RK; Palotie A; Freimer NB; Taskinen MR; Ripatti S
    PLoS Genet; 2016 May; 12(5):e1006078. PubMed ID: 27227539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monogenic and polygenic causes of low and extremely low LDL-C levels in patients referred to specialty lipid clinics: Genetics of low LDL-C.
    Jakubowski B; Shao Y; McNeal C; Xing C; Ahmad Z
    J Clin Lipidol; 2021; 15(5):658-664. PubMed ID: 34340953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common variants at 30 loci contribute to polygenic dyslipidemia.
    Kathiresan S; Willer CJ; Peloso GM; Demissie S; Musunuru K; Schadt EE; Kaplan L; Bennett D; Li Y; Tanaka T; Voight BF; Bonnycastle LL; Jackson AU; Crawford G; Surti A; Guiducci C; Burtt NP; Parish S; Clarke R; Zelenika D; Kubalanza KA; Morken MA; Scott LJ; Stringham HM; Galan P; Swift AJ; Kuusisto J; Bergman RN; Sundvall J; Laakso M; Ferrucci L; Scheet P; Sanna S; Uda M; Yang Q; Lunetta KL; Dupuis J; de Bakker PI; O'Donnell CJ; Chambers JC; Kooner JS; Hercberg S; Meneton P; Lakatta EG; Scuteri A; Schlessinger D; Tuomilehto J; Collins FS; Groop L; Altshuler D; Collins R; Lathrop GM; Melander O; Salomaa V; Peltonen L; Orho-Melander M; Ordovas JM; Boehnke M; Abecasis GR; Mohlke KL; Cupples LA
    Nat Genet; 2009 Jan; 41(1):56-65. PubMed ID: 19060906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in finding pathogenic DNA copy number variations in dyslipidemia.
    Iacocca MA; Dron JS; Hegele RA
    Curr Opin Lipidol; 2019 Apr; 30(2):63-70. PubMed ID: 30664016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polygenic risk scores for the diagnosis and management of dyslipidemia.
    Brunham LR; Trinder M
    Curr Opin Endocrinol Diabetes Obes; 2022 Apr; 29(2):95-100. PubMed ID: 35034034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically.
    Wang J; Dron JS; Ban MR; Robinson JF; McIntyre AD; Alazzam M; Zhao PJ; Dilliott AA; Cao H; Huff MW; Rhainds D; Low-Kam C; Dubé MP; Lettre G; Tardif JC; Hegele RA
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2439-2445. PubMed ID: 27765764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of 12 novel loci that confer susceptibility to early-onset dyslipidemia.
    Yamada Y; Kato K; Oguri M; Horibe H; Fujimaki T; Yasukochi Y; Takeuchi I; Sakuma J
    Int J Mol Med; 2019 Jan; 43(1):57-82. PubMed ID: 30365130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of genetic risk for dyslipidemia.
    Yamada Y; Matsuo H; Warita S; Watanabe S; Kato K; Oguri M; Yokoi K; Metoki N; Yoshida H; Satoh K; Ichihara S; Aoyagi Y; Yasunaga A; Park H; Tanaka M; Nozawa Y
    Genomics; 2007 Nov; 90(5):551-8. PubMed ID: 17919884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of variants identified in caucasian genome-wide association studies for plasma high-density lipoprotein cholesterol and triglycerides levels in Mexican dyslipidemic study samples.
    Weissglas-Volkov D; Aguilar-Salinas CA; Sinsheimer JS; Riba L; Huertas-Vazquez A; Ordoñez-Sánchez ML; Rodriguez-Guillen R; Cantor RM; Tusie-Luna T; Pajukanta P
    Circ Cardiovasc Genet; 2010 Feb; 3(1):31-8. PubMed ID: 20160193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An increased burden of common and rare lipid-associated risk alleles contributes to the phenotypic spectrum of hypertriglyceridemia.
    Johansen CT; Wang J; Lanktree MB; McIntyre AD; Ban MR; Martins RA; Kennedy BA; Hassell RG; Visser ME; Schwartz SM; Voight BF; Elosua R; Salomaa V; O'Donnell CJ; Dallinga-Thie GM; Anand SS; Yusuf S; Huff MW; Kathiresan S; Cao H; Hegele RA
    Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1916-26. PubMed ID: 21597005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy.
    Arnedo M; Taffé P; Sahli R; Furrer H; Hirschel B; Elzi L; Weber R; Vernazza P; Bernasconi E; Darioli R; Bergmann S; Beckmann JS; Telenti A; Tarr PE;
    Pharmacogenet Genomics; 2007 Sep; 17(9):755-64. PubMed ID: 17700364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic determinants of inherited susceptibility to hypercholesterolemia - a comprehensive literature review.
    Paththinige CS; Sirisena ND; Dissanayake V
    Lipids Health Dis; 2017 Jun; 16(1):103. PubMed ID: 28577571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of genetic variants for adult lipid levels with lipid levels in children. The Generation R Study.
    Latsuzbaia A; Jaddoe VWV; Hofman A; Franco OH; Felix JF
    J Lipid Res; 2016 Dec; 57(12):2185-2192. PubMed ID: 27777320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.